What is the current annual EBITDA of ZTS?

As of today, ZTS annual EBITDA is $4.08B

What is 1-year change in ZTS annual EBITDA?

ZTS annual EBITDA is up +5.01% year-over-year

What is 3-year change in ZTS annual EBITDA?

ZTS annual EBITDA is up +20.37% over the past 3 years

How far is ZTS annual EBITDA from its all-time high?

ZTS annual EBITDA is currently at its all-time high

How does ZTS annual EBITDA rank versus sector peers?

ZTS annual EBITDA is higher than 97.36% of companies in Healthcare sector

When is ZTS next annual earnings release?

As of today, the next annual earnings release for ZTS has not been scheduled

What is the current quarterly EBITDA of ZTS?

As of today, ZTS quarterly EBITDA is $947.00M

What is ZTS quarterly EBITDA most recent change?

ZTS quarterly EBITDA was down -10.66% on December 31, 2025

What is 1-year change in ZTS quarterly EBITDA?

ZTS quarterly EBITDA is up +6.64% year-over-year

How far is ZTS quarterly EBITDA from its all-time high?

ZTS quarterly EBITDA is currently -14.84% below its historical high of $1.11B set on June 30, 2025

How does ZTS quarterly EBITDA rank versus sector peers?

ZTS quarterly EBITDA is higher than 96.81% of companies in Healthcare sector

When is ZTS next earnings release?

The next earnings release for ZTS is on May 5, 2026

What is the current TTM EBITDA of ZTS?

As of today, ZTS TTM EBITDA is $4.08B

What is ZTS TTM EBITDA most recent change?

ZTS TTM EBITDA was up +1.47% on December 31, 2025

What is 1-year change in ZTS TTM EBITDA?

ZTS TTM EBITDA is up +5.01% year-over-year

How far is ZTS TTM EBITDA from its all-time high?

ZTS TTM EBITDA is currently at its all-time high

How does ZTS TTM EBITDA rank versus sector peers?

ZTS TTM EBITDA is higher than 97.26% of companies in Healthcare sector

When is ZTS next earnings release?

The next earnings release for ZTS is on May 5, 2026

Zoetis Inc. (ZTS) EBITDA History & Chart Since 2009

Annual EBITDA

$4.08B$195.00M+5.01%

December 31, 2025

Summary

Current Value: As of today, ZTS annual EBITDA is $4.08B, up +5.01% on December 31, 2025
Historical Performance: ZTS annual EBITDA is up +20.37% over the past 3 years, up +50.70% over the past 5 years
All-Time High Comparison: ZTS annual EBITDA is currently at its all-time high
3-Year Low Comparison: ZTS annual EBITDA is +20.37% above its 3-year low of $3.39B reached on an earlier date
Sector Comparison: ZTS annual EBITDA is higher than 97.36% of companies in Healthcare sector

EBITDA Chart

Add series to chart

Add series to chart1/6

Performance

ZTS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$4.08B	+5.0%	+20.4%	+50.7%	+726.7%
Quarterly EBITDA	Dec 31, 25	$947.00M	+6.6%	+17.1%	+52.3%	+371.1%
TTM EBITDA	Dec 31, 25	$4.08B	+5.0%	+20.4%	+50.7%	+1931.8%
Price	Mar 3, 26	$127.75	-25.1%	-25.1%	-14.4%	–
PE Ratio	Mar 3, 26	21.21	-32.0%	-44.1%	-51.4%	–
Annual Revenue	Dec 31, 25	$9.47B	+2.3%	+17.2%	+41.8%	+164.3%
Annual EPS	Dec 31, 25	$6.02	+10.2%	+34.0%	+76.0%	+2637.5%
	Dec 31, 25	$3.60B	+6.0%	+22.9%	+58.5%	+1064.1%
Annual Net Income	Dec 31, 25	$2.67B	+7.1%	+26.6%	+63.4%	+2308.1%

EBITDA Highs

ZTS Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$4.08B	Dec 31, 25	at high
5Y	$4.08B	Dec 31, 25	at high
All	$4.08B	Dec 31, 25	at high

EBITDA Lows

ZTS Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$3.39B	N/A	+20.4%
5Y	$2.71B	N/A	+50.7%
All	$405.00M	Dec 31, 09	+908.4%

EBITDA History

Year	Value	Change
2025	$4.08B	+5.0%
2024	$3.89B	+9.2%
2023	$3.56B	+4.9%
2022	$3.39B	+4.4%
2021	$3.25B	+20.0%
2020	$2.71B	+11.5%
2019	$2.43B	+11.0%
2018	$2.19B	+11.2%
2017	$1.97B	+19.8%

Year	Value	Change
2016	$1.64B	+28.3%
2015	$1.28B	+9.1%
2014	$1.17B	+14.0%
2013	$1.03B	-2.3%
2012	$1.05B	+18.6%
2011	$889.00M	+80.0%
2010	$494.00M	+22.0%
2009	$405.00M	-

FAQ

What is the current annual EBITDA of ZTS?
As of today, ZTS annual EBITDA is $4.08B
What is 1-year change in ZTS annual EBITDA?
ZTS annual EBITDA is up +5.01% year-over-year
What is 3-year change in ZTS annual EBITDA?
ZTS annual EBITDA is up +20.37% over the past 3 years
How far is ZTS annual EBITDA from its all-time high?
ZTS annual EBITDA is currently at its all-time high
How does ZTS annual EBITDA rank versus sector peers?
ZTS annual EBITDA is higher than 97.36% of companies in Healthcare sector
When is ZTS next annual earnings release?
As of today, the next annual earnings release for ZTS has not been scheduled

Quarterly EBITDA

$947.00M$113.00M-10.66%

December 31, 2025

Summary

Current Value: As of today, ZTS quarterly EBITDA is $947.00M, down -10.66% on December 31, 2025
Historical Performance: ZTS quarterly EBITDA is up +6.64% year-over-year, up +17.06% over the past 3 years
All-Time High Comparison: ZTS quarterly EBITDA is currently -14.84% below its historical high of $1.11B set on June 30, 2025
3-Year Low Comparison: ZTS quarterly EBITDA is +17.06% above its 3-year low of $809.00M reached on an earlier date
Sector Comparison: ZTS quarterly EBITDA is higher than 96.81% of companies in Healthcare sector

Performance

ZTS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Dec 31, 25	$947.00M	-10.7%	+6.6%	+17.1%	+52.3%
Annual EBITDA	Dec 31, 25	$4.08B	–	+5.0%	+20.4%	+50.7%
TTM EBITDA	Dec 31, 25	$4.08B	+1.5%	+5.0%	+20.4%	+50.7%
Price	Mar 3, 26	$127.75	+4.2%	-25.1%	-25.1%	-14.4%
PE Ratio	Mar 3, 26	21.21	+2.7%	-32.0%	-44.1%	-51.4%
Quarterly Revenue	Dec 31, 25	$2.39B	-0.5%	+3.0%	+17.0%	+32.1%
Quarterly EPS	Dec 31, 25	$1.37	-15.5%	+6.7%	+39.2%	+83.3%
	Dec 31, 25	$826.00M	-11.8%	+8.0%	+19.7%	+61.0%
Quarterly Net Income	Dec 31, 25	$603.00M	-16.4%	+3.8%	+31.1%	+68.4%

Quarterly EBITDA Highs

ZTS Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.11B	Jun 30, 25	-14.8%
3Y	$1.11B	Jun 30, 25	-14.8%
5Y	$1.11B	Jun 30, 25	-14.8%
All	$1.11B	Jun 30, 25	-14.8%

Quarterly EBITDA Lows

ZTS Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$888.00M	N/A	+6.6%
3Y	$809.00M	N/A	+17.1%
5Y	$622.00M	N/A	+52.3%
All	$191.00M	Jun 30, 11	+395.8%

Quarterly EBITDA History

Month	Value	Change
Dec 2025	$947.00M	-10.7%
Sep 2025	$1.06B	-4.7%
Jun 2025	$1.11B	+15.2%
Mar 2025	$965.00M	+8.7%
Dec 2024	$888.00M	-14.7%
Sep 2024	$1.04B	+0.8%
Jun 2024	$1.03B	+11.4%
Mar 2024	$927.00M	+11.0%
Dec 2023	$835.00M	-9.4%
Sep 2023	$922.00M	-3.5%
Jun 2023	$955.00M	+12.6%
Mar 2023	$848.00M	+4.8%
Dec 2022	$809.00M	-3.5%
Sep 2022	$838.00M	-0.6%
Jun 2022	$843.00M	-6.6%
Mar 2022	$903.00M	+26.6%
Dec 2021	$713.00M	-14.9%
Sep 2021	$838.00M	+0.2%
Jun 2021	$836.00M	-3.2%
Mar 2021	$864.00M	+38.9%
Dec 2020	$622.00M	-19.7%
Sep 2020	$775.00M	+16.7%
Jun 2020	$664.00M	+2.3%
Mar 2020	$649.00M	+6.6%
Dec 2019	$609.00M	-9.2%
Sep 2019	$671.00M	+7.5%
Jun 2019	$624.00M	+18.6%
Mar 2019	$526.00M	-2.0%
Dec 2018	$537.00M	-12.4%
Sep 2018	$613.00M	+12.1%

Month	Value	Change
Jun 2018	$547.00M	+5.0%
Mar 2018	$521.00M	-8.9%
Dec 2017	$572.00M	+9.4%
Sep 2017	$523.00M	+18.3%
Jun 2017	$442.00M	+2.8%
Mar 2017	$430.00M	+12.0%
Dec 2016	$384.00M	-12.1%
Sep 2016	$437.00M	+4.5%
Jun 2016	$418.00M	+3.2%
Mar 2016	$405.00M	+43.1%
Dec 2015	$283.00M	-21.2%
Sep 2015	$359.00M	+12.2%
Jun 2015	$320.00M	+4.2%
Mar 2015	$307.00M	+24.3%
Dec 2014	$247.00M	-23.5%
Sep 2014	$323.00M	+10.2%
Jun 2014	$293.00M	-5.5%
Mar 2014	$310.00M	+23.0%
Dec 2013	$252.00M	-3.1%
Sep 2013	$260.00M	+7.9%
Jun 2013	$241.00M	-13.0%
Mar 2013	$277.00M	+37.8%
Dec 2012	$201.00M	-26.9%
Sep 2012	$275.00M	-14.1%
Jun 2012	$320.00M	+24.0%
Mar 2012	$258.00M	+23.4%
Dec 2011	$209.00M	-19.6%
Sep 2011	$260.00M	+36.1%
Jun 2011	$191.00M	-5.0%
Mar 2011	$201.00M	-

FAQ

What is the current quarterly EBITDA of ZTS?
As of today, ZTS quarterly EBITDA is $947.00M
What is ZTS quarterly EBITDA most recent change?
ZTS quarterly EBITDA was down -10.66% on December 31, 2025
What is 1-year change in ZTS quarterly EBITDA?
ZTS quarterly EBITDA is up +6.64% year-over-year
How far is ZTS quarterly EBITDA from its all-time high?
ZTS quarterly EBITDA is currently -14.84% below its historical high of $1.11B set on June 30, 2025
How does ZTS quarterly EBITDA rank versus sector peers?
ZTS quarterly EBITDA is higher than 96.81% of companies in Healthcare sector
When is ZTS next earnings release?
The next earnings release for ZTS is on May 5, 2026

TTM EBITDA

$4.08B$59.00M+1.47%

December 31, 2025

Summary

Current Value: As of today, ZTS TTM EBITDA is $4.08B, up +1.47% on December 31, 2025
Historical Performance: ZTS TTM EBITDA is up +5.01% year-over-year, up +20.37% over the past 3 years
All-Time High Comparison: ZTS TTM EBITDA is currently at its all-time high
3-Year Low Comparison: ZTS TTM EBITDA is +22.35% above its 3-year low of $3.34B reached on March 31, 2023
Sector Comparison: ZTS TTM EBITDA is higher than 97.26% of companies in Healthcare sector

Performance

ZTS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Dec 31, 25	$4.08B	+1.5%	+5.0%	+20.4%	+50.7%
Annual EBITDA	Dec 31, 25	$4.08B	–	+5.0%	+20.4%	+50.7%
Quarterly EBITDA	Dec 31, 25	$947.00M	-10.7%	+6.6%	+17.1%	+52.3%
Price	Mar 3, 26	$127.75	+4.2%	-25.1%	-25.1%	-14.4%
PE Ratio	Mar 3, 26	21.21	+2.7%	-32.0%	-44.1%	-51.4%
TTM Revenue	Dec 31, 25	$9.47B	+0.7%	+2.3%	+17.2%	+41.8%
TTM EPS	Dec 31, 25	$6.02	+1.5%	+10.2%	+34.0%	+75.9%
	Dec 31, 25	$3.60B	+1.7%	+6.0%	+22.9%	+58.5%
TTM Net Income	Dec 31, 25	$2.67B	+0.8%	+7.1%	+26.6%	+63.4%

TTM EBITDA Highs

ZTS TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$4.08B	Dec 31, 25	at high
3Y	$4.08B	Dec 31, 25	at high
5Y	$4.08B	Dec 31, 25	at high
All	$4.08B	Dec 31, 25	at high

TTM EBITDA Lows

ZTS TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$3.89B	N/A	+5.0%
3Y	$3.34B	Mar 31, 23	+22.4%
5Y	$2.71B	N/A	+50.7%
All	$201.00M	Mar 31, 11	+1931.8%

TTM EBITDA History

Month	Value	Change
Dec 2025	$4.08B	+1.5%
Sep 2025	$4.03B	+0.5%
Jun 2025	$4.01B	+2.0%
Mar 2025	$3.93B	+1.0%
Dec 2024	$3.89B	+1.4%
Sep 2024	$3.84B	+3.2%
Jun 2024	$3.72B	+2.1%
Mar 2024	$3.64B	+2.2%
Dec 2023	$3.56B	+0.7%
Sep 2023	$3.53B	+2.4%
Jun 2023	$3.45B	+3.4%
Mar 2023	$3.34B	-1.6%
Dec 2022	$3.39B	+2.9%
Sep 2022	$3.30B	0.0%
Jun 2022	$3.30B	+0.2%
Mar 2022	$3.29B	+1.2%
Dec 2021	$3.25B	+2.9%
Sep 2021	$3.16B	+2.0%
Jun 2021	$3.10B	+5.9%
Mar 2021	$2.93B	+7.9%
Dec 2020	$2.71B	+0.5%
Sep 2020	$2.70B	+4.0%
Jun 2020	$2.59B	+1.6%
Mar 2020	$2.55B	+5.1%
Dec 2019	$2.43B	+3.1%
Sep 2019	$2.36B	+2.5%
Jun 2019	$2.30B	+3.5%
Mar 2019	$2.22B	+0.2%
Dec 2018	$2.22B	-1.6%
Sep 2018	$2.25B	+4.2%

Month	Value	Change
Jun 2018	$2.16B	+5.1%
Mar 2018	$2.06B	+4.6%
Dec 2017	$1.97B	+10.6%
Sep 2017	$1.78B	+5.1%
Jun 2017	$1.69B	+1.4%
Mar 2017	$1.67B	+1.5%
Dec 2016	$1.64B	+6.5%
Sep 2016	$1.54B	+5.3%
Jun 2016	$1.47B	+7.2%
Mar 2016	$1.37B	+7.7%
Dec 2015	$1.27B	+2.9%
Sep 2015	$1.23B	+3.0%
Jun 2015	$1.20B	+2.3%
Mar 2015	$1.17B	-0.3%
Dec 2014	$1.17B	-0.4%
Sep 2014	$1.18B	+5.7%
Jun 2014	$1.12B	+4.9%
Mar 2014	$1.06B	+3.2%
Dec 2013	$1.03B	+5.2%
Sep 2013	$979.00M	-1.5%
Jun 2013	$994.00M	-7.4%
Mar 2013	$1.07B	+1.8%
Dec 2012	$1.05B	-0.8%
Sep 2012	$1.06B	+1.4%
Jun 2012	$1.05B	+14.1%
Mar 2012	$918.00M	+6.6%
Dec 2011	$861.00M	+32.1%
Sep 2011	$652.00M	+66.3%
Jun 2011	$392.00M	+95.0%
Mar 2011	$201.00M	-

FAQ

What is the current TTM EBITDA of ZTS?
As of today, ZTS TTM EBITDA is $4.08B
What is ZTS TTM EBITDA most recent change?
ZTS TTM EBITDA was up +1.47% on December 31, 2025
What is 1-year change in ZTS TTM EBITDA?
ZTS TTM EBITDA is up +5.01% year-over-year
How far is ZTS TTM EBITDA from its all-time high?
ZTS TTM EBITDA is currently at its all-time high
How does ZTS TTM EBITDA rank versus sector peers?
ZTS TTM EBITDA is higher than 97.26% of companies in Healthcare sector
When is ZTS next earnings release?
The next earnings release for ZTS is on May 5, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

ZTS Official Website www.zoetis.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1555280/000155528026000011/0001555280-26-000011-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1555280/000155528026000011/0001555280-26-000011-index.htm
ZTS Profile on Yahoo Finance finance.yahoo.com/quote/ZTS
ZTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zts